Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex

References

• Barbieri M, Di Filippo C, Esposito A, Marfella R, Rizzo MR, D'Amico M, Ferraraccio F, Di Ronza C, Duan SZ, Mortensen RM, et al. 2012. Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-gamma-knockout (CM-PGKO) mice. PLoS One. 7:e35999.
   PubMed Web of Science ®Google Scholar
• Beyer CE, Dwyer JM, Piesla MJ, Platt BJ, Shen R, Rahman Z, Chan K, Manners MT, Samad TA, Kennedy JD, et al. 2010. Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiol Dis. 39:148–155.
   PubMed Web of Science ®Google Scholar
• Bioque M, Garcia-Bueno B, MacDowell KS, Meseguer A, Saiz PA, Parellada M, Gonzalez-Pinto A, Rodriguez-Jimenez R, Lobo A, Leza JC, et al. 2013. Peripheral endocannabinoid system dysregulation in first-episode psychosis. Neuropsychopharmacology. 38:2568–2577.
   PubMed Web of Science ®Google Scholar
• Blankman JL, Simon GM, Cravatt BF. 2007. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol. 14:1347–1356.
   PubMed Web of Science ®Google Scholar
• Bowles NP, Hill MN, Bhagat SM, Karatsoreos IN, Hillard CJ, McEwen BS. 2012. Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice. Neuroscience. 204:83–89.
   PubMed Web of Science ®Google Scholar
• Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Bradley AJ, Dinan TG. 2010. A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol. 24(4 Suppl.):91–118.
   PubMed Web of Science ®Google Scholar
• Brocato B, Zoerner AA, Janjetovic Z, Skobowiat C, Gupta S, Moore BM, Slominski A, Zhang J, Schenone M, Phinehas R, et al. 2013. Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity. Placenta. 34:983–989.
   PubMed Web of Science ®Google Scholar
• Corena-McLeod MP, Oliveros A, Charlesworth C, Madden B, Liang YQ, Boules M, Shaw A, Williams K, Richelson E. 2008. Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression. Brain Res. 1233:8–19.
   PubMed Web of Science ®Google Scholar
• Crowe MS, Nass SR, Gabella KM, Kinsey SG. 2014. The endocannabinoid system modulates stress, emotionality, and inflammation. Brain Behav Immun. 42:1-5.
   PubMed Web of Science ®Google Scholar
• De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V. 2003. Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis. 2:5
   PubMedGoogle Scholar
• Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1946–1949.
   PubMed Web of Science ®Google Scholar
• Dlugos A, Childs E, Stuhr KL, Hillard CJ, de WH. 2012. Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology. 37:2416–2427.
   PubMed Web of Science ®Google Scholar
• Eggan SM, Hashimoto T, Lewis DA. 2008. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry. 65:772–784.
   PubMed Web of Science ®Google Scholar
• Fernandez-Espejo E, Viveros MP, Nunez L, Ellenbroek BA, Rodriguez de FF. 2009. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl). 206:531–549.
   PubMed Web of Science ®Google Scholar
• Ferretjans R, Moreira FA, Teixeira AL, Salgado JV. 2012. The endocannabinoid system and its role in schizophrenia: a systematic review of the literature. Rev Bras Psiquiatr. 34 (Suppl 2):S163–S177.
   PubMed Web of Science ®Google Scholar
• Fidaleo M, Fanelli F, Ceru MP, Moreno S. 2014. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands. Curr Med Chem. 21:2803–2821.
   PubMed Web of Science ®Google Scholar
• Garcia-Bueno B, Bioque M, Mac-Dowell KS, Barcones MF, Martinez-Cengotitabengoa M, Pina-Camacho L, Rodriguez-Jimenez R, Saiz PA, Castro C, Lafuente A, et al. 2014. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull. 40:376–387.
   PubMed Web of Science ®Google Scholar
• Garcia-Gutierrez MS, Perez-Ortiz JM, Gutierrez-Adan A, Manzanares J. 2010. Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br J Pharmacol. 160:1773–1784.
   PubMed Web of Science ®Google Scholar
• Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkotter J, Piomelli D. 2004. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology. 29:2108–2114.
   PubMed Web of Science ®Google Scholar
• Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR. 2006. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 1071:10–23.
   PubMed Web of Science ®Google Scholar
• Gorzalka BB, Hill MN. 2011. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 35:1575–1585.
   PubMed Web of Science ®Google Scholar
• Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT, Karatsoreos IN, Mackie K, Viau V, Pickel VM, et al. 2011. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci. 31:10506–10515.
   PubMed Web of Science ®Google Scholar
• Holtzman CW, Trotman HD, Goulding SM, Ryan AT, Macdonald AN, Shapiro DI, Brasfield JL, Walker EF. 2013. Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience. 249:172–191.
   PubMed Web of Science ®Google Scholar
• Hong S, Zheng G, Wu X, Snider NT, Owyang C, Wiley JW. 2011. Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed rat. Gastroenterology. 140:627–637.
   PubMed Web of Science ®Google Scholar
• Hu W, Zhang M, Czeh B, Zhang W, Flugge G. 2011. Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats. Brain Res Bull. 85:374–379.
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y, Morikawa M, Inada T, Watanabe Y, Takahashi M, et al. 2010. Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry. 67:974–982.
   PubMed Web of Science ®Google Scholar
• Kallendrusch S, Hobusch C, Ehrlich A, Ziebell S, Ueda N, Geisslinger G, Koch M, Dehghani F. 2012. Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections. PLoS One. 7:e33537
   PubMed Web of Science ®Google Scholar
• Krishnamurthy S, Garabadu D, Reddy NR, Joy KP. 2011. Risperidone in ultra low dose protects against stress in the rodent cold restraint model by modulating stress pathways. Neurochem Res. 36:1750–1758.
   PubMed Web of Science ®Google Scholar
• Kucerova J, Tabiova K, Drago F, Micale V. 2014. Therapeutic potential of cannabinoids in schizophrenia. Recent Pat CNS Drug Discov. 9:13–25.
   PubMedGoogle Scholar
• Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D. 1999. Elevated endogenous cannabinoids in schizophrenia. Neuroreport. 10:1665–1669.
   PubMed Web of Science ®Google Scholar
• Leza JC, Salas E, Sawicki G, Russell JC, Radomski MW. 1998. The effects of stress on homeostasis in JCR-LA-cp rats: the role of nitric oxide. J Pharmacol Exp Ther. 286:1397–1403.
   PubMed Web of Science ®Google Scholar
• MacDowell KS, Caso JR, Martin-Hernandez D, Madrigal JL, Leza JC, Garcia-Bueno B. 2015. Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress. Int J Neuropsychopharmacol. 18(3). doi:10.1093/ijnp/pyu070
   Web of Science ®Google Scholar
• MacDowell KS, Garcia-Bueno B, Madrigal JL, Parellada M, Arango C, Mico JA, Leza JC. 2013. Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation. Int J Neuropsychopharmacol. 16:121–135.
   PubMed Web of Science ®Google Scholar
• Mackie K. 2005. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol. 168:299–325.
   PubMedGoogle Scholar
• Madrigal JL, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo J, Leza JC. 2001. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology. 24:420–429.
   PubMed Web of Science ®Google Scholar
• Marco EM, Echeverry-Alzate V, Lopez-Moreno JA, Gine E, Penasco S, Viveros MP. 2014. Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain. Behav Pharmacol. 25:547–556.
   PubMed Web of Science ®Google Scholar
• Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:561–564.
   PubMed Web of Science ®Google Scholar
• McKinney MK, Cravatt BF. 2005. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem. 74:411–432.
   PubMed Web of Science ®Google Scholar
• McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka BB. 2012. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. Eur Neuropsychopharmacol. 22:664–671.
   PubMed Web of Science ®Google Scholar
• McLaughlin RJ, Hill MN, Dang SS, Wainwright SR, Galea LA, Hillard CJ, Gorzalka BB. 2013. Upregulation of CB1 receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure. Behav Brain Res. 237:333–337.
   PubMed Web of Science ®Google Scholar
• McLaughlin RJ, Hill MN, Gorzalka BB. 2014. A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior. Neurosci Biobehav Rev. 42:116–131.
   PubMed Web of Science ®Google Scholar
• McPartland JM, Guy GW, Di M,V. 2014. Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system. PLoS One. 9:e89566
   PubMed Web of Science ®Google Scholar
• Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, et al. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 50:83–90.
   PubMed Web of Science ®Google Scholar
• Mechoulam R, Shohami E. 2007. Endocannabinoids and traumatic brain injury. Mol Neurobiol. 36:68–74.
   PubMed Web of Science ®Google Scholar
• Melis M, Carta G, Pistis M, Banni S. 2013. Physiological role of peroxisome proliferator-activated receptors type α on dopamine systems. CNS Neurol Disord Drug Targets. 12:70–77.
   PubMed Web of Science ®Google Scholar
• Morena M, Patel S, Bains JS, Hill MN. 2015. Neurobiological Interactions Between Stress and the Endocannabinoid System. Neuropsychopharmacology. 41:80-102.
   PubMed Web of Science ®Google Scholar
• Morgan NH, Stanford IM, Woodhall GL. 2009. Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology. 57:356–368.
   PubMed Web of Science ®Google Scholar
• Muguruza C, Lehtonen M, Aaltonen N, Morentin B, Meana JJ, Callado LF. 2013. Quantification of endocannabinoids in postmortem brain of schizophrenic subjects. Schizophr Res. 148:145–150.
   PubMed Web of Science ®Google Scholar
• Munro S, Thomas KL, Abu-Shaar M. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:61–65.
   PubMed Web of Science ®Google Scholar
• Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, Potenza MN, Bailey CR, Lin SF, Najafzadeh S, et al. 2013. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry. 18:1034–1040.
   PubMed Web of Science ®Google Scholar
• Ortega-Alvaro A, Aracil-Fernandez A, Garcia-Gutierrez MS, Navarrete F, Manzanares J. 2011. Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology. 36:1489–1504.
   PubMed Web of Science ®Google Scholar
• Patel S, Kingsley PJ, Mackie K, Marnett LJ, Winder DG. 2009. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology. 34:2699–2709.
   PubMed Web of Science ®Google Scholar
• Patel S, Rademacher DJ, Hillard CJ. 2003. Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther. 306:880–888.
   PubMed Web of Science ®Google Scholar
• Piomelli D. 2003. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 4:873–884.
   PubMed Web of Science ®Google Scholar
• Reisenberg M, Singh PK, Williams G, Doherty P. 2012. The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling. Philos Trans R Soc Lond B Biol Sci. 367:3264–3275.
   PubMed Web of Science ®Google Scholar
• Rogoz Z. 2013. Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy. Pharmacol Rep. 65:1535–1544.
   PubMed Web of Science ®Google Scholar
• Ross RA. 2003. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol. 140:790–801.
   PubMed Web of Science ®Google Scholar
• Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. 2007. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 152:1092–1101.
   PubMed Web of Science ®Google Scholar
• Secher A, Husum H, Holst B, Egerod KL, Mellerup E. 2010. Risperidone treatment increases CB1 receptor binding in rat brain. Neuroendocrinology. 91:155–168.
   PubMed Web of Science ®Google Scholar
• Serretti A, Fabbri C. 2013. Shared genetics among major psychiatric disorders. Lancet. 381:1339–1341.
   PubMed Web of Science ®Google Scholar
• Sugiura T, Kobayashi Y, Oka S, Waku K. 2002. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids. 66:173–192.
   PubMed Web of Science ®Google Scholar
• Sun Y, Alexander SP, Garle MJ, Gibson CL, Hewitt K, Murphy SP, Kendall DA, Bennett AJ. 2007. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. Br J Pharmacol. 152:734–743.
   PubMed Web of Science ®Google Scholar
• Tsuboi K, Ikematsu N, Uyama T, Deutsch DG, Tokumura A, Ueda N. 2013. Biosynthetic pathways of bioactive N-acylethanolamines in brain. CNS Neurol Disord Drug Targets. 12:7–16.
   PubMed Web of Science ®Google Scholar
• Uriguen L, Garcia-Fuster MJ, Callado LF, Morentin B, La Harpe R, Casado V, Lluis C, Franco R, Garcia-Sevilla JA, Meana JJ. 2009. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment. Psychopharmacology (Berl). 206:313–324.
   PubMed Web of Science ®Google Scholar
• Valverde O, Torrens M. 2012. CB1 receptor-deficient mice as a model for depression. Neuroscience. 204:193–206.
   PubMed Web of Science ®Google Scholar
• Viveros MP, Marco EM, File SE. 2005. Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav. 81:331–342.
   PubMed Web of Science ®Google Scholar
• Waleh NS, Cravatt BF, Apte-Deshpande A, Terao A, Kilduff TS. 2002. Transcriptional regulation of the mouse fatty acid amide hydrolase gene. Gene. 291:203–210.
   PubMed Web of Science ®Google Scholar
• Wang HR, Woo YS, Bahk WM. 2013. Atypical antipsychotics in the treatment of posttraumatic stress disorder. Clin Neuropharmacol. 36:216–222.
   PubMed Web of Science ®Google Scholar
• Wu XY, Hu YT, Guo L, Lu J, Zhu QB, Yu E, Wu JL, Shi LG, Huang ML, Bao AM. 2015. Effect of pentobarbital and isoflurane on acute stress response in rat. Physiol Behav. 145:118–121.
   PubMed Web of Science ®Google Scholar
• Wu YW, Bi YP, Kou XX, Xu W, Ma LQ, Wang KW, Gan YH, Ma XC. 2010. 17-Beta-estradiol enhanced allodynia of inflammatory temporomandibular joint through upregulation of hippocampal TRPV1 in ovariectomized rats. J Neurosci. 30:8710–8719.
   PubMed Web of Science ®Google Scholar
• Xing G, Carlton J, Zhang L, Jiang X, Fullerton C, Li H, Ursano R. 2011. Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: implication for PTSD and drug abuse. Neurosci Lett. 502:5–9.
   PubMed Web of Science ®Google Scholar
• Zoppi S, Perez Nievas BG, Madrigal JL, Manzanares J, Leza JC, Garcia-Bueno B. 2011. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology. 36:805–818.
   PubMed Web of Science ®Google Scholar